Adriane Fugh-Berman
Adriane Fugh-Berman is an associate professor in the department of pharmacology and physiology, and in the department of family medicine, at Georgetown University Medical Center. She is also the director of PharmedOut, a research center at Georgetown University Medical Center dedicated to researching the effects of pharmaceutical industry marketing on drug prescriptions.[1]
Education
Fugh-Berman graduated from Georgetown University School of Medicine, after which she completed her residency in family medicine at Montefiore Medical Center.[1]
Career
Prior to joining Georgetown, Fugh-Berman worked as a medical officer at the National Institute for Child Health and Human Development, and with the Reproductive Toxicology Center.[2]
Research
Fugh-Berman has published multiple studies regarding the relationship between physicians and the pharmaceutical industry, as well as on the efforts of this industry to publish ghostwritten articles in peer-reviewed journals.[2]
Views
Fugh-Berman has been critical of multiple popular pharmaceutical drugs and treatments, such as testosterone replacement therapy[3] and flibanserin.[4] She has also criticized how the numerical values used to diagnose diabetes and high cholesterol have been lowered over time, and has criticized Eli Lilly for allegedly inventing premenstrual dysphoric disorder to sell its drug Sarafem.[5]
References
- 1 2 "Adriane Fugh-Berman, M.D.". Physicians Committee for Responsible Medicine. Retrieved 17 April 2016.
- 1 2 "Adriane Fugh-Berman". Georgetown University. Retrieved 17 April 2016.
- ↑ Ungar, Laura (12 June 2013). "Popular 'low T' therapy divides the medical field". Louisville Courier-Journal. Retrieved 17 April 2016.
- ↑ Pollack, Andrew (4 June 2015). "'Viagra for Women' Is Backed by an F.D.A. Panel". New York Times. Retrieved 17 April 2016.
- ↑ Andriote, John-Manuel (3 April 2012). "Legal Drug-Pushing: How Disease Mongers Keep Us All Doped Up". The Atlantic. Retrieved 17 April 2016.